Basaloid Cell Hyperplasia Overlying Dermatofibroma.
Options
BORIS DOI
Publisher DOI
PubMed ID
41133724
Description
Dermatofibromas (DFs) are benign neoplasms of the dermis typically found on the extremities of young adults. In approximately 3-5% of cases, basaloid cell hyperplasia (BCH) is observed overlying DFs. BCH is characterized by the proliferation of basaloid cells within the epidermis. BCH and superficial basal cell carcinoma (BCC) share many histological features, making their differentiation challenging. It is therefore unclear if the proliferation of basaloid cells in DFs represents an inductive process or, conversely, a malignant transformation indicative of BCC. The primary objective of our study was to determine whether BCH can be distinguished from superficial BCC using histology and immunhistological techniques. The histological and immunohistochemical characteristics of 43 DF samples with overlying BCH revealed significant similarities in staining patterns with those of superficial BCC described in the literature. These findings point to the need for innovative methods, such as molecular techniques, to refine diagnostic accuracy.
Date of Publication
2025-10-10
Publication Type
Article
Subject(s)
Keyword(s)
Ber-EP4
•
CK-20
•
Ki-67
•
basal cell carcinoma
•
basaloid cell hyperplasia
•
dermatofibroma
Language(s)
en
Contributor(s)
Pablo, Izarra | |
Marwa, Zohdy |
Additional Credits
Series
Dermatopathology
Publisher
MDPI
ISSN
2296-3529
Access(Rights)
open.access